Cipla Share price

Q: How to buy Cipla Share at Choice?

To buy Cipla stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cipla, choose your preferred order type, and place the trade.

CIPLA

Healthcare Large Cap

1399.2

2.70 (-0.19%)

NSE

BSE

Last updated on 22 May, 2026 | 15:50 IST

BUYSELL

Today's High

1409.60

Today's Low

1392.00

52 Week Low

1165.70

52 Week High

1673.00

Free Demat with Zero AMC*

Cipla Chart

ChartIQ

TradingView

Cipla Share Key Metrics

Volume

9.17 L

Market Cap

113024.67 CR

LTQ@LTP

1@1399.20

ATP

1400.56

Var Margin

12.68 %

Circuit Range

1261.8-1542

Delivery %

61.06 %

Value

128.48 CR

ASM/GSM

No

Market Lot

1

Summary

Cipla share price is ₹1399.2 as of 24 May, 2026. The stock Cipla intraday movement has stayed between ₹1392.00 and ₹1409.60, while on a 52-week basis,Cipla price 52 week high is ₹1673.00 & its 52 week low is ₹1165.70.

In terms of trading activity, Cipla has recorded a volume of 917323 shares, The Cipla has a market cap of ₹807780677 CR. The stock’s Average Traded Price (ATP) stands at ₹1400.56, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1399.20.

Cipla operates within a circuit range of ₹1261.80 – ₹1542.00, with a Value of ₹128.48 CR. The Delivery Percentage for the day is 61.06%. Additionally, Cipla currently falls under the No framework, and trades with a market lot size of 1.

Cipla Fundamentals

P/E Ratio

29.13

P/B Ratio

3.28

Div. Yield

0.93

Sector P/E

70.19

Sector P/B

3.46

Sec. Div. Yield

0.55

Cipla Resistance and Support

Pivot 1405.17

Resistance

First Resistance

1412.64

Second Resistance

1423.37

Third Resistance

1430.84

Support

First Support

1394.44

Second Support

1386.97

Third Support

1376.24

Cipla Futures & Options

Cipla Ltd Share Price

1399.2

-2.7 (-0.19%)

Cipla Option Chain

View Price, OI, Greeks & More...

View All

26MAY26

1401.80

-2.70 (0.19%)

30JUN26

1397.30

-2.60 (0.19%)

28JUL26

1405.00

-3.50 (0.25%)

CIPLA|26MAY26 CE 1390.00

16.05 -3.8 (-19.14%)

CIPLA|26MAY26 PE 1400.00

9.65 -0.6 (-5.85%)

Cipla Shareholding Pattern

2017-18
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

29.21%

Mutual Fund

18.66%

Insurance

11.24%

Foreign Institutional Investors

22.55%

Domestic Institutional Investors

2.07%

Retail

16.26%

Others

0.01%

Total Promoters

MAR '26

29.21%

Cipla Corporate Actions

Date	Agenda
2026-05-13	Audited Results & Final Dividend
2026-01-23	Quarterly Results
2025-10-30	Quarterly Results
2025-07-25	Quarterly Results
2025-05-13	Audited Results & Final Dividend
2025-01-28	Quarterly Results

Cipla News

Cipla Limited

Cipla's Board recommended a final dividend of Rs.13 per equity share for the financial year ended March 31, 2026. The record date for this dividend is set for June 5, 2026, and it will be paid within 30 days of the upcoming AGM.

May 21 2026 17:05:00

Sensex Today | Stock Market LIVE Updates: Nifty abve 23,700; Caplin Point surges 10%

Cipla's shares were among the top gainers in the market on May 11, 2026, increasing by 6.63% to ₹1,415.60, as reported in a live stock market update.

May 14 2026 14:05:00

Sensex Today | Stock Market LIVE Updates: Sensex soars 1,000 points, Nifty above 23,700

Cipla shares rose 8% despite reporting disappointing Q4 results. The rally is being driven by other factors influencing the pharmaceutical stock.

May 14 2026 14:05:00

Sensex Today | Stock Market LIVE Updates: Nifty holds 300-point gain; Apollo Hospital at 52-week high

Cipla reported a 55% year-on-year decline in Q4 FY26 consolidated net profit to ₹554.6 crore and a 2.8% fall in revenue to ₹6,541.2 crore. Despite the weak financial performance, the company's shares surged over 7.9% on May 14, 2026, driven by optimistic management commentary regarding future growth, particularly a target of $1 billion in annual US sales by the end of FY27. Additionally, the board recommended a final dividend of ₹13 per equity share for FY26.

May 14 2026 14:05:00

Sensex Today | Stock Market LIVE Updates: Nifty extends gains, surges past 23,750 mark, Sensex up 1,000 pts

Indian equities saw a rally, with the Nifty 50 and Sensex gaining significantly. Cipla Limited's stock price increased by approximately 6.8% amidst this broader market positive movement.

May 14 2026 13:05:00

Sensex Today | Stock Market LIVE Updates: Nifty marks a sharp recovery from falls, nears day's high

Cipla's shares soared 8% despite reporting disappointing Q4 results, driven by investor optimism regarding the company's strategic expansion plans, including potential acquisitions in the South African drug market and an ambitious target to achieve $1 billion in US revenue by FY27.

May 14 2026 11:05:00

Sensex Today | Stock Market LIVE Updates: Nifty IT extends losses to 700 points, minor recovery in mkt

Cipla's stock surged 8% driven by the company's strategic outlook, which includes plans for acquisitions to secure a leading position in the South African drug market and an aspiration to achieve $1 billion in US revenue by FY27. This positive market reaction occurred despite what was described as a disappointing fourth-quarter performance.

May 14 2026 11:05:00

Sensex Today | Stock Market LIVE Updates: Nifty falls to 23,400; Midcap, Banking, Sensex slump to turn negative

The article provides live updates on the stock market, covering movements of various indices and individual stocks. Cipla's stock performance is noted within the context of overall market and sector trends, reflecting general market sentiment rather than a specific corporate event.

May 14 2026 11:05:00

Cipla shares rally 8% despite 55% YoY slump in Q4 profit. Why Citi, Nuvama, other brokerages hiked target

Cipla's shares rallied 8% despite a reported 55% year-on-year slump in Q4 net profit, as several brokerages, including Citi and Nuvama, either upgraded ratings or hiked target prices. Analysts cited strong future growth prospects from branded prescription sales, market share gains, and new product launches in key markets as reasons for their optimism.

May 14 2026 11:05:00

Cipla shares jump 7% after at least six analyst upgrades on Q4 results, outlook

Cipla's shares rallied following multiple analyst upgrades, driven by a positive outlook for the company's upcoming Q4 results and a robust US business pipeline, including potential from generic Advair and gRevlimid.

May 14 2026 09:05:00

NSE : 694

BSE : 500087

ISIN : INE059A01026

Cipla Management

Name	Position
Y K Hamied	Chairman
Kamil Hamied	Non Independent & Non Executive Director

Cipla Similar Stocks

Sun Pharmaceutical Industries Ltd.

1844.60

-46.70 (2.47%)

Divi's Laboratories Ltd.

6887.00

29.00 (0.42%)

Torrent Pharmaceuticals Ltd.

4486.20

17.00 (0.38%)

Apollo Hospitals Enterprise Ltd.

8362.50

54.00 (0.65%)

Dr. Reddy's Laboratories Ltd.

1307.20

-11.30 (0.86%)

Mankind Pharma Ltd.

2479.40

-34.70 (1.38%)

Max Healthcare Institute Ltd.

1023.25

-67.85 (6.22%)

Zydus Lifesciences Ltd.

1038.95

2.50 (0.24%)

Lupin Ltd.

2281.80

-2.70 (0.12%)

Aurobindo Pharma Ltd.

1463.50

-83.20 (5.38%)

Cipla FAQs

The Buying Price of Cipla share is 1399.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Cipla stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cipla, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Cipla shares is 29.13. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Cipla shares is 3.28. Useful to assess the stock's value relative to its book value.

To assess Cipla’s valuation compare Sector P/E, P/B which are 70.19 & 3.46 with sector averages, along with growth rates and financial metrics.

The Market Cap of Cipla is 113024.67 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Cipla share price is 1673.00 & 1165.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Cipla belongs to the Healthcare sector.